Physician profile
Robert T Bennett
NPI 1194720912
$2,524.94
in general payments reported to CMS, 2019-2025
25 companies · $759 in 2025
The $759 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $28.58 · 2021: $98.48 · 2022: $306 · 2023: $351 · 2024: $795 · 2025: $759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,905.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $410.06 | 2022-2025 | Xtandi |
| Edap Technomed INC | $327.00 | 2024 | |
| Laborie Medical Technologies Corp. | $262.02 | 2023 | |
| Dendreon Pharmaceuticals LLC | $240.51 | 2025 | Provenge |
| Boston Scientific Corporation | $129.84 | 2023-2025 | Axonics, Spaceoar Vue System - 10ml |
| Endo USA, INC. | $124.46 | 2024 | Xiaflex |
| Neotract INC. | $120.46 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $118.42 | 2022 | |
| Pfizer INC. | $101.20 | 2024-2025 | |
| Urogen Pharma, INC. | $98.48 | 2021 | |
| Urovant Sciences INC | $76.80 | 2022 | |
| Coloplast Corp | $70.24 | 2025 | |
| Photocure INC | $65.26 | 2019-2025 | Cysview |
| Angiodynamics, INC. | $50.32 | 2024 | Nanoknife |
| Procept Biorobotics Corporation | $42.41 | 2024 | Aquabeam System |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $42.06 | 2020-2025 | Cysto-Nephro Videoscope, Uropass, Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $36.63 | 2024-2025 | |
| Karl Storz Endoscopy-America | $35.06 | 2019 | |
| Janssen Biotech, INC. | $31.20 | 2023-2025 | Erleada |
| Medtronic, INC. | $31.18 | 2023-2024 | Interstim |
| Novartis Pharmaceuticals Corporation | $27.21 | 2024 | |
| Abbvie INC. | $26.03 | 2020-2023 | Botox |
| 180 Medical, INC. | $23.28 | 2025 | Gentlecath |
| Sumitomo Pharma America, INC. | $17.84 | 2025 | Orgovyx |
| Fujifilm Healthcare Americas Corporation | $16.97 | 2023 | Arietta Precision |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.